Careers  |  Sign In  |  Register

Latest in Travel Medicine

An experimental vaccine developed by Canadian scientists at NewLink Genetics Corporation is on the verge of launching its first human clinical trial, according to a report by Reuters. The new drug uses the pathogen vesicular stomatitis virus,where one virus gene is replaced by an Ebola gene, which then...
A second experimental Ebola drug from Tekemira Pharmaceuticals is advancing through clinical trials from healthy volunteers to affected patients in Africa thanks to help from the FDA, the New York Times reports. Last month, the FDA had stopped the trial for TKM-Ebola because of side effects, but taking into...
The National Institutes of Health announced that it will begin human testing for an experimental Ebola vaccine as early as September, according to an article published by CNN. This comes the same day that the CDC raised its travel alert to level three for Guinea, Liberia, and Sierra Leone, something it has...